3,4-Dichloro-2-methylpyridine - CAS 103949-58-2
Catalog: |
BB001268 |
Product Name: |
3,4-Dichloro-2-methylpyridine |
CAS: |
103949-58-2 |
Synonyms: |
3,4-dichloro-2-methylpyridine; 3,4-dichloro-2-methylpyridine |
IUPAC Name: | 3,4-dichloro-2-methylpyridine |
Description: | 3,4-Dichloro-2-methylpyridine (CAS# 103949-58-2) is a useful research chemical. |
Molecular Weight: | 162.02 |
Molecular Formula: | C6H5Cl2N |
Canonical SMILES: | CC1=NC=CC(=C1Cl)Cl |
InChI: | InChI=1S/C6H5Cl2N/c1-4-6(8)5(7)2-3-9-4/h2-3H,1H3 |
InChI Key: | RKTIAZVXWYFNJG-UHFFFAOYSA-N |
Boiling Point: | 194.717 °C at 760 mmHg |
Density: | 1.319 g/cm3 |
Storage: | Inert atmosphere, 2-8 °C |
MDL: | MFCD09839289 |
LogP: | 2.69680 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P330, P332+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-110885343-A | Mint-based dicarbo-phosphorus chiral tertiary phosphine derivative, and preparation method and application thereof | 20191211 |
WO-2021074620-A1 | [1,4]oxazepino[2,3-c]qui noli none derivatives as blc6 inhibitors | 20191014 |
US-2021047294-A1 | Imidazolyl pyrimidinylamine compounds as cdk2 inhibitors | 20190814 |
WO-2021030537-A1 | Imidazolyl pyrimidinylamine compounds as cdk2 inhibitors | 20190814 |
WO-2021028336-A1 | (hetero)aryl-methyl-thio-beta-d-galactopyranoside derivatives | 20190809 |
PMID | Publication Date | Title | Journal |
20809122 | 20110601 | Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin | Cancer chemotherapy and pharmacology |
12671715 | 20030407 | A Phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473) | British journal of cancer |
12659211 | 20030315 | A comparison of the quantitative methods for the analysis of the platinum-containing anticancer drug [cis-[amminedichloro(2-methylpyridine)]platinum(II)] (ZD0473) by HPLC coupled to either a triple quadrupole mass spectrometer or an inductively coupled plasma mass spectrometer | Analytical chemistry |
Complexity: | 97.1 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 160.9799046 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 160.9799046 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 12.9 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.5 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Pyridines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS